Denali Therapeutics Inc.
DNLI
$19.00
$1.166.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.39% | 0.32% | -12.70% | -19.54% | -24.58% |
| Total Receivables | 35.71% | 0.00% | -10.53% | -36.52% | -33.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.23% | 11.04% | 69.55% | 14.23% | -2.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.58% | 0.68% | -9.75% | -18.77% | -23.98% |
|
|
|||||
| Total Current Assets | 1.58% | 0.68% | -9.75% | -18.77% | -23.98% |
| Net Property, Plant & Equipment | 8.82% | 79.18% | 80.02% | 75.37% | 51.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -61.85% | -54.58% | -39.64% | -46.31% | 137.83% |
| Total Assets | -27.40% | -22.38% | -19.59% | 19.09% | 17.56% |
|
|
|||||
| Total Accounts Payable | -29.70% | -22.19% | -28.65% | 17.44% | 711.68% |
| Total Accrued Expenses | -2.94% | 17.54% | 7.58% | 5.99% | 0.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.26% | 32.36% | 53.41% | 65.76% | 15.30% |
| Total Finance Division Other Current Liabilities | 38.79% | 94.11% | 38.70% | -- | 57.13% |
| Total Other Current Liabilities | 38.79% | 94.11% | 38.70% | -- | 57.13% |
| Total Current Liabilities | 3.51% | 22.17% | 11.26% | 31.07% | 22.36% |
|
|
|||||
| Total Current Liabilities | 3.51% | 22.17% | 11.26% | 31.07% | 22.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.78% | -8.04% | -6.94% | -5.99% | -5.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.38% | -- | -- | -- | 940.63% |
| Total Liabilities | -4.50% | 20.49% | 18.34% | 17.51% | 14.41% |
|
|
|||||
| Common Stock & APIC | 4.05% | 4.26% | 4.40% | 28.89% | 29.37% |
| Retained Earnings | -35.02% | -36.37% | -37.27% | -37.88% | -42.89% |
| Treasury Stock & Other | -80.09% | 135.31% | 257.18% | 214.15% | 949.31% |
| Total Common Equity | -29.75% | -25.95% | -22.86% | 19.28% | 17.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.75% | -25.95% | -22.86% | 19.28% | 17.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.75% | -25.95% | -22.86% | 19.28% | 17.90% |
|
|
|||||